Francotyp-Postalia, a stock-listed international active group of companies which provides digital business solutions, mailing, shipping & office solutions and mail services, has acquired all shares in the operating companies of Azolver Group. Azolver Group focuses
Tags :Andreas Müller
Sonova Holding, a provider of audio solutions, entered into an agreement with Sennheiser electronic & Co. to acquire Sennheiser’s Consumer Division. The Sennheiser Consumer Division, which concentrates on the business of headphones and hearables
Metall Zug and Komax Holding entered into a definitive agreement under which the Metall Zug Group will contribute its Business Unit Wire Processing (Schleuniger) into Komax in exchange for a 25% participation in Komax Holding. The
ZF Friedrichshafen, a global technology company in powertrain and suspension engineering as well as active and passive safety technology, enters into an asset deal for the acquisition of the specialized adhesive films technology for side
Veertly, a European start-up platform for virtual and hybrid events and digital collaboration, has received a seed funding of 1.9 million Euros (2 million Swiss Francs). The recently concluded financing round is to be used primarily to
Asml Holding has agreed to sell a 100% stake in BG Medical Applications, SwissOptic and SwissOptic Co., to Jenoptik. BG Medical Applications is a supplier of high-precision, custom optical components for the medical technology sector based
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
Platinum Equity announced that it has signed a definitive agreement to acquire Solenis, a global producer of specialty chemicals used in water-intensive industries, from Clayton, Dubilier & Rice and BASF in a transaction that implies
Grünenthal announced the acquisition of Mestex through the purchase of all of its shares and outstanding options. Mestex is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the
VectivBio Holding AG announced its initial public offering and listing of its shares on Nasdaq (ticker symbol VECT). VectivBio is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments